Establishment Labs Holdings Inc. Finance Lease, Right-of-Use Asset, Amortization
Establishment Labs Holdings Inc. (ESTA) reported Finance Lease, Right-of-Use Asset, Amortization of $25.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2022-05-10
- Establishment Labs Holdings Inc. finance lease, right-of-use asset, amortization for the quarter ending 2022-03-31 was $25.00K, a 28.57% decline year-over-year.
- Establishment Labs Holdings Inc. finance lease, right-of-use asset, amortization for the quarter ending 2021-12-31 was $29.00K, a 61.11% increase year-over-year.
- Establishment Labs Holdings Inc. finance lease, right-of-use asset, amortization for the quarter ending 2021-09-30 was $30.00K, a 50.00% increase year-over-year.
- Establishment Labs Holdings Inc. finance lease, right-of-use asset, amortization for the quarter ending 2021-06-30 was $32.00K, a 45.45% increase year-over-year.
- Establishment Labs Holdings Inc. finance lease, right-of-use asset, amortization for fiscal 2021 was $126.00K, a 57.50% increase from fiscal 2020.
- Establishment Labs Holdings Inc. finance lease, right-of-use asset, amortization for fiscal 2020 was $80.00K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2022-03-31 | $25.00K 10-Q · filed 2022-05-10 | $54.00K derived: sum of 2 quarters · filed 2022-05-10 | $84.00K derived: sum of 3 quarters · filed 2022-05-10 | $116.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $59.00K derived: sum of 2 quarters · filed 2022-03-01 | $91.00K derived: sum of 3 quarters · filed 2022-03-01 | $126.00K 10-K · filed 2022-03-01 |
| 2021-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $62.00K derived: sum of 2 quarters · filed 2021-11-09 | $97.00K 10-Q · filed 2021-11-09 | $115.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $67.00K 10-Q · filed 2021-07-30 | $85.00K derived: sum of 3 quarters · filed 2022-05-10 | $105.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-03-31 | $35.00K 10-Q · filed 2022-05-10 | $53.00K derived: sum of 2 quarters · filed 2022-05-10 | $73.00K derived: sum of 3 quarters · filed 2022-05-10 | $95.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $38.00K derived: sum of 2 quarters · filed 2022-03-01 | $60.00K derived: sum of 3 quarters · filed 2022-03-01 | $80.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $42.00K derived: sum of 2 quarters · filed 2021-11-09 | $62.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $42.00K 10-Q · filed 2021-07-30 | ||
| 2020-03-31 | $20.00K 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |